Since the fetus is semiallogenic to the mother, mechanisms have evolve
d to protect fetal tissue from the maternal immune response. Among the
se mechanisms is the expression of cell-surface complement regulatory
proteins at the maternal-fetal interface. However, beginning in the th
ird trimester, fetal blood cells are exposed to actively-transported I
gG antibody. Thus, we speculated that fetal blood cells would require
expression of one or more complement regulators by the early third tri
mester. Using now cytometry and Western blots, we have demonstrated th
e presence of three important complement regulatory proteins in the ci
rculating blood cells of human fetuses. These findings are consistent
with the putative biological role of the cell-surface complement regul
atory proteins.